Immunity against COVID-19 may persist for at least five months after being infected with the SARS-CoV-2 virus, according to a study led by an Indian-origin researcher in the US. The researchers from the University of Arizona studied the production of antibodies from a sample of nearly 6,000 people infected with the novel coronavirus.

The device called “AJO-Neo” is developed by Professor Samir K. Pal &his group at S.N. Bose National Centre For Basic Sciences (SNBNCBS), Kolkata, an autonomous research Institute under the Department of Science and Technology (DST), Government of India.

Genomic data collection is accelerating in historically understudied and excluded populations. The information will fill knowledge gaps, spur medical discoveries and lead to more targeted and appropriate care; however, it comes with significant risk if ungoverned.

The researchers estimate the distribution of serial intervals for 468 confirmed cases of 2019 novel coronavirus disease reported in China as of February 8, 2020. The mean interval was 3.96 days (95% CI 3.53–4.39 days), SD 4.75 days (95% CI 4.46–5.07 days); 12.6% of case reports indicated presymptomatic transmission.

Studies in mild-to-moderate cases as well as severe disease leave us still searching for a magic pill. (Editorial)

The objective of the study wast to assess the effectiveness of hydroxychloroquine in patients admitted to hospital with coronavirus disease 2019 (covid-19) pneumonia who require oxygen.

The objective of the study was to assess the efficacy and safety of hydroxychloroquine plus standard of care compared with standard of care alone in adults with coronavirus disease 2019 (covid-19).

The scientists at ICMR-NIV, Pune have developed and validated the completely indigenous IgG ELISA test for antibody detection for SARS-CoV-2. On external validation, the IgG test kit produced by ICMR-NIV, Pune has been found to have sensitivity and specificity of 98.7% and 100% respectively. ELISA test has the advantage of processing 90 samples together in a single run of two-and-a-half hours. Moreover, ELISA based testing is easily possible even at district level as the ELISA kit has inactivated virus.

Members of the public are being mobilized by the government to donate to the national COVID-19 resource mobilization Initiative set up by the Prime Minister. Cash, food and other supplies are being donated by the public, including the private sector.

The COVID-19 pandemic caused by SARS-CoV-2 coronavirus threatens global public health. Currently, neutralizing antibodies (NAbs) versus this virus are expected to correlate with recovery and protection of this disease. However, the characteristics of these antibodies have not been well studied in association with the clinical manifestations in patients

Pages